Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:34:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. No substantive content changes are evident.
    Difference
    0.1%
    Check dated 2026-02-05T14:25:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.4' replacing 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:48:40.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a Locations section listing Florida, New Jersey, New York, and Pennsylvania. Removed the state-specific location sections and the HHS Vulnerability Disclosure, and updated the page revision to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-24T15:41:10.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; this change appears to be a minor technical update with no alteration to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:48:05.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The government funding/status notice has been removed from the page. Core study details, eligibility criteria, and contact/location information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.